The European Regional Development Fund (ERDF) provides co-funding to public and private bodies in all EU regions to reduce economic, social and territorial disparities. It aims to make Europe and its regions more competitive and smarter, through innovation and support to small and medium-sized businesses (SMEs), as well as digitization and digital connectivity, greener, low-carbon and resilient, more connected by enhancing mobility, more social, supporting effective and inclusive employment, education, skills, social inclusion and equal access to healthcare, as well as enhancing the role of culture and sustainable tourism, and closer to citizens, supporting locally-led development and sustainable urban development across the EU. INSIGHT is co-funded as part of the Union’s response to the COVID-19 pandemic.
About the Conference
The MIND Foundation’s INSIGHT conference is at the forefront of psychedelic research in medicine and society. Clinicians and entrepreneurs, patients and artists, journalists and regulators, newcomers to the field and seniors meet to rethink psychedelics.
This year’s edition places an additional focus on psychedelic neuroscience and societal topics such as non-clinical forms of use, psychedelics and mindfulness in the business world, the philosophy of psychedelic experience, patient and therapist spiritualities, and learning from indigenous communities.
We offer regular on-site and online tickets, and a contingent of reduced tickets. VIP tickets as well as EFPIA/Industry tickets are available.
Conference Venue
The venue for INSIGHT 2023 is Langenbeck-Virchow-Haus, Luisenstraße 58/59, 10117 Berlin (Mitte).
OUR SPONSORS
OUR COLLABORATION PARTNERS
OUR PROMOTIONAL PARTNERS
OUR MEDIA PARTNERS
PRE-CONFERENCE WORKSHOPS
INSIGHT 2023 IS HERE
With the feedback and experience from 2021, we will make INSIGHT 2023 even greater, for example, by adding new elements such as multilingual conference tracks, invited symposia, and policy interaction. Participatory formats will allow us to openly discuss the pressing questions of our time, such as:
How can we critically learn from the past and ongoing studies? Which therapist trainings have evolved, and how to assess their quality? What is needed to make the transition from scientific research to societal integration?
INSIGHT 2023 will also report results from the largest science-initiated psilocybin study so far: the German EPIsoDE trial. We are building bridges between physicians and psychotherapists, researchers, and the psychedelic industry and closing the gap between practitioners and the academic world of psychedelic research.
Testimonials
Read what speakers and participants have said about INSIGHT
